Dr JANNIER Sarah
Fiche personne
coordonnées
Service de pédiatrie onco-hématologie
Hôpital de Hautepierre
Avenue Molière
67098 STRASBOURG Cedex
03 88 12 80 97
Territoire
Alsace
Statut
Hospitalier
Recherche
Expertises :
- Clinique:Pédiatrie
Publications
Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis.
Lemelle L, Guillemot D, Hermann AL, Gauthier A, Carton M, Corradini N, Rome A, Berlanga P, Jourdain A, Marie Cardine A, Jannier S, Boutroux H, Defachelles AS, Aerts I, Geoerger B, Karanian M, Doz F, Brisse HJ, Schleiermacher G, Delattre O, Pierron G, Orbach D
Expert Rev Anticancer Ther. 2023 07 11;:
Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology.
Sabo AN, Jannier S, Becker G, Lessinger JM, Entz-Werlé N, Kemmel V
Pharmaceutics. 2021 Mar 30;13(4):
SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers.
Jannier S, Kemmel V, Sebastia Sancho C, Chammas A, Sabo AN, Pencreach E, Farace F, Chenard MP, Lhermitte B, Geoerger B, Aerts I, Frappaz D, Leblond P, André N, Ducassou S, Corradini N, Bertozzi AI, Guérin E, Vincent F, Velten M, Entz-Werle N
Cancers (Basel). 2020 Oct 20;12(10):